Overview

Tailored Treatment in Metastatic Colorectal Cancer

Status:
Terminated
Trial end date:
2008-02-01
Target enrollment:
Participant gender:
Summary
To compare the response rate of single agent chemotherapy in advanced colorectal cancer given as standard treatment versus tailored treatment in a randomised phase III trial.
Phase:
Phase 3
Details
Lead Sponsor:
Vejle Hospital
Treatments:
Capecitabine
Fluorouracil
Irinotecan